See more : Green Leaf Innovations, Inc. (GRLF) Income Statement Analysis – Financial Results
Complete financial analysis of Hemagen Diagnostics, Inc. (HMGN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hemagen Diagnostics, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Hiper Global Ltd. (HIPR.TA) Income Statement Analysis – Financial Results
- ThinTech Materials Technology Co., Ltd. (3663.TWO) Income Statement Analysis – Financial Results
- Farmers Bancorp (Frankfort IN) (FABP) Income Statement Analysis – Financial Results
- Ace Software Exports Limited (ACESOFT.BO) Income Statement Analysis – Financial Results
- Agilent Technologies, Inc. (A) Income Statement Analysis – Financial Results
Hemagen Diagnostics, Inc. (HMGN)
About Hemagen Diagnostics, Inc.
Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.
Source: https://incomestatements.info
Category: Stock Reports